Achilles Therapeutics Companies
Achilles Therapeutics is a developer of immunotherapies that aims to revolutionize cancer treatment by targeting clonal neoantigens present on all cancer cells. Their patient-specific therapies harness the immune system to destroy cancer cells without harming healthy tissues. By targeting truncal tumor neo-antigens and flags on the surface of cancer cells, Achilles Therapeutics offers next-generation precision T cell therapies. With a focus on solid tumor cancer treatment, the organization is dedicated to developing innovative solutions to improve patient outcomes in the fight against cancer.
Investors
Connections from
Headquarters:
London, England, United Kingdom
Founded Date:
2016
Employee Number:
1-10
Industry:
Advanced Longevity (R&D)
Technology:
Advanced and Next Generation Therapies (Various)